Please assess the completion status of the following clinical trial:

Trial Title: Comparison of a Step-Up Versus a Step-Down Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Presence of a new episode of dyspepsia, defined as episodic or persistent symptoms including abdominal pain or discomfort and which are, in the opinion of the general practitioner, referable to the upper gastrointestinal tract.~* Over 18 years of age~* Informed consent (written) given.~Exclusion Criteria:~* Use of prescribed acid suppressive medication during 3 months before consult~* Investigated by upper gastrointestinal endoscopy one year before inclusion~* Malignancy~* Contraindication to the study medication~* Pregnancy~* Alarming symptoms like weight loss, bleeding, and disturbed food passage~* Patients with insufficient comprehension of the Dutch language

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Step-up (Type: OTHER): Stepwise treatment:~* step1: antacid (+placebo proton pump inhibitor)~* step2: H2-receptor antagonist~* step3: proton pump inhibitor (+ placebo antacid)
- step-down (Type: OTHER): Stepwise treatment:~* step1: proton pump inhibitor (+placebo antacid)~* step2: H2-receptor antagonist~* step3: antacid (+proton pump inhibitor)

Based on this trial design, predict the completion outcome and termination type (if applicable).